Q Linea (Sweden) Performance
| QLINEA Stock | SEK 0.77 0.09 10.47% |
The firm holds a Beta of 0.0393, which implies not very significant fluctuations relative to the market. As returns on the market increase, Q Linea's returns are expected to increase less than the market. However, during the bear market, the loss of holding Q Linea is expected to be smaller as well. At this point, Q linea AB has a negative expected return of -1.84%. Please make sure to check Q Linea's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Q linea AB performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Q linea AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 10.1 M | |
| Total Cashflows From Investing Activities | -23.8 M |
QLINEA |
Q Linea Relative Risk vs. Return Landscape
If you would invest 289.00 in Q linea AB on September 23, 2024 and sell it today you would lose (212.00) from holding Q linea AB or give up 73.36% of portfolio value over 90 days. Q linea AB is generating negative expected returns and assumes 5.1709% volatility on return distribution over the 90 days horizon. Simply put, 46% of stocks are less volatile than QLINEA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Q Linea Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Q Linea's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Q linea AB, and traders can use it to determine the average amount a Q Linea's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.3562
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | QLINEA |
Estimated Market Risk
| 5.17 actual daily | 46 54% of assets are more volatile |
Expected Return
| -1.84 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.36 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Q Linea is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Q Linea by adding Q Linea to a well-diversified portfolio.
Q Linea Fundamentals Growth
QLINEA Stock prices reflect investors' perceptions of the future prospects and financial health of Q Linea, and Q Linea fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on QLINEA Stock performance.
| Return On Equity | -0.72 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (13.93) % | |||
| Current Valuation | 287.15 M | |||
| Shares Outstanding | 29.21 M | |||
| Price To Book | 1.68 X | |||
| Price To Sales | 21.31 X | |||
| Revenue | 9.34 M | |||
| EBITDA | (221.99 M) | |||
| Cash And Equivalents | 15.09 M | |||
| Cash Per Share | 11.76 X | |||
| Debt To Equity | 0.20 % | |||
| Book Value Per Share | 7.78 X | |||
| Cash Flow From Operations | (255.05 M) | |||
| Earnings Per Share | (8.34) X | |||
| Total Asset | 466.63 M | |||
About Q Linea Performance
By analyzing Q Linea's fundamental ratios, stakeholders can gain valuable insights into Q Linea's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Q Linea has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Q Linea has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Q-linea AB researches, develops, manufactures, and sells instruments and disposables for infection diagnostics. Q-linea AB was founded in 2008 and is based in Uppsala, Sweden. Q Linea operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 61 people.Things to note about Q linea AB performance evaluation
Checking the ongoing alerts about Q Linea for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Q linea AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Q linea AB generated a negative expected return over the last 90 days | |
| Q linea AB has high historical volatility and very poor performance | |
| Q linea AB has some characteristics of a very speculative penny stock | |
| Q linea AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 9.34 M. Net Loss for the year was (231.24 M) with loss before overhead, payroll, taxes, and interest of (24.63 M). | |
| Q linea AB has accumulated about 15.09 M in cash with (255.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 75.0% of the company shares are owned by institutional investors |
- Analyzing Q Linea's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Q Linea's stock is overvalued or undervalued compared to its peers.
- Examining Q Linea's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Q Linea's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Q Linea's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Q Linea's stock. These opinions can provide insight into Q Linea's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for QLINEA Stock analysis
When running Q Linea's price analysis, check to measure Q Linea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q Linea is operating at the current time. Most of Q Linea's value examination focuses on studying past and present price action to predict the probability of Q Linea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q Linea's price. Additionally, you may evaluate how the addition of Q Linea to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |